ZR001
/ Shenzhen Loongen Biotechnology
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2026
ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's Disease
(clinicaltrials.gov)
- P1 | N=8 | Not yet recruiting | Sponsor: Qianfoshan Hospital
First-in-human • New P1 trial • CNS Disorders • Gene Therapies • Movement Disorders • Myelodysplastic Syndrome • Parkinson's Disease
1 to 1
Of
1
Go to page
1